Clinical Cancer Research, Vol 2, Issue 1 215-221, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines

JJ Chiu, MK Sgagias and KH Cowan
Medicine Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

The effect of interleukin 6 (IL-6) on normal and human mammary carcinoma epithelial cells was studied. IL-6 inhibited the growth of estrogen receptor-positive [ER(+)] breast cancer cell lines, which underwent apoptosis with prolonged treatment. In contrast, ER(-) breast cancer cell lines were resistant to IL-6-mediated growth inhibition. By examining the components of the IL-6 receptor (IL-6R) system, we found that ER(+) breast cancer cells expressed predominantly soluble IL-6Ralpha, whereas the ER(-) breast cancer cells expressed primarily the transmembrane form of the IL-6R, gp130. In addition, detectable levels of IL-6 were secreted into the medium by ER(-) but not ER(+) breast cancer cells. Furthermore, the supernatant obtained from IL-6-secreting, ER(-) cells suppressed the growth of IL-6-sensitive, ER(+) breast cancer cells in a paracrine fashion. Although IL-6 is secreted by ER(-) breast cancer cells, this cytokine does not seem to stimulate the proliferation of these cells in an autocrine fashion. These studies indicate that IL-6 can regulate the growth of normal and transformed human mammary epithelial cells differentially, and that IL-6 secretion by some ER(-) breast cancer cells can function as a paracrine growth factor, suppressing the growth of ER(+) breast cancer cells in vitro.

This article has been cited by other articles:

				L. F. P. Silva, B. E. Etchebarne, M. S. Weber Nielsen, J. S. Liesman, M. Kiupel, and M. J. VandeHaar Intramammary Infusion of Leptin Decreases Proliferation of Mammary Epithelial Cells in Prepubertal Heifers J Dairy Sci, August 1, 2008; 91(8): 3034 - 3044. [Abstract] [Full Text] [PDF]

				E. P. Hines, J. L. Rayner, R. Barbee, R. A. Moreland, A. Valcour, J. E. Schmid, and S. E. Fenton Assays for Endogenous Components of Human Milk: Comparison of Fresh and Frozen Samples and Corresponding Analytes in Serum J Hum Lact, May 1, 2007; 23(2): 144 - 156. [Abstract] [PDF]

				A. H. Gordon, R. J. O'Keefe, E. M. Schwarz, R. N. Rosier, and J. E. Puzas Nuclear Factor-{kappa}B-Dependent Mechanisms in Breast Cancer Cells Regulate Tumor Burden and Osteolysis in Bone Cancer Res., April 15, 2005; 65(8): 3209 - 3217. [Abstract] [Full Text] [PDF]

				M. Heneweer, M. Muusse, M. Dingemans, P. C. de Jong, M. van den Berg, and J. T. Sanderson Co-culture of Primary Human Mammary Fibroblasts and MCF-7 Cells as an In Vitro Breast Cancer Model Toxicol. Sci., February 1, 2005; 83(2): 257 - 263. [Abstract] [Full Text] [PDF]

				Y. Hu, H. Sun, J. Drake, F. Kittrell, M. C. Abba, L. Deng, S. Gaddis, A. Sahin, K. Baggerly, D. Medina, et al. From Mice to Humans: Identification of Commonly Deregulated Genes in Mammary Cancer via Comparative SAGE Studies Cancer Res., November 1, 2004; 64(21): 7748 - 7755. [Abstract] [Full Text] [PDF]

				K. S. Selander, L. Li, L. Watson, M. Merrell, H. Dahmen, P. C. Heinrich, G. Muller-Newen, and K. W. Harris Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy Cancer Res., October 1, 2004; 64(19): 6924 - 6933. [Abstract] [Full Text] [PDF]

				R. T. Chatterton Jr., A. S. Geiger, S. A. Khan, I. B. Helenowski, B. D. Jovanovic, and P. H. Gann Variation in Estradiol, Estradiol Precursors, and Estrogen-related Products in Nipple Aspirate Fluid from Normal Premenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 928 - 935. [Abstract] [Full Text] [PDF]

				J. B Cologne, G. B Sharp, K. Neriishi, P. K Verkasalo, C. E Land, and K. Nakachi Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure Int. J. Epidemiol., June 1, 2004; 33(3): 485 - 492. [Abstract] [Full Text] [PDF]

				L. F. P. Silva, M. J. VandeHaar, M. S. Weber Nielsen, and G. W. Smith Evidence for a Local Effect of Leptin in Bovine Mammary Gland J Dairy Sci, December 1, 2002; 85(12): 3277 - 3286. [Abstract] [Full Text] [PDF]

				J. A. Hutt and J. W. DeWille Oncostatin M Induces Growth Arrest of Mammary Epithelium via a CCAAT/enhancer-binding Protein {delta}-dependent Pathway Mol. Cancer Ther., June 1, 2002; 1(8): 601 - 610. [Abstract] [Full Text] [PDF]

				R. Buettner, L. B. Mora, and R. Jove Activated STAT Signaling in Human Tumors Provides Novel Molecular Targets for Therapeutic Intervention Clin. Cancer Res., April 1, 2002; 8(4): 945 - 954. [Abstract] [Full Text] [PDF]

				A. Hobisch, R. Ramoner, D. Fuchs, S. Godoy-Tundidor, G. Bartsch, H. Klocker, and Z. Culig Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype Clin. Cancer Res., September 1, 2001; 7(9): 2941 - 2948. [Abstract] [Full Text] [PDF]

				M. J. Reed and A. Purohit Breast Cancer and the Role of Cytokines in Regulating Estrogen Synthesis: An Emerging Hypothesis Endocr. Rev., October 1, 1997; 18(5): 701 - 715. [Abstract] [Full Text]

				J. A. Hutt, J. P. O'Rourke, and J. DeWille Signal Transducer and Activator of Transcription 3 Activates CCAAT Enhancer-binding Protein delta Gene Transcription in G0 Growth-arrested Mouse Mammary Epithelial Cells and in Involuting Mouse Mammary Gland J. Biol. Chem., September 8, 2000; 275(37): 29123 - 29131. [Abstract] [Full Text] [PDF]

				L. H. Wang, X. Y. Yang, K. Mihalic, W. Xiao, D. Li, and W. L. Farrar Activation of Estrogen Receptor Blocks Interleukin-6-inducible Cell Growth of Human Multiple Myeloma Involving Molecular Cross-talk between Estrogen Receptor and STAT3 Mediated by Co-regulator PIAS3 J. Biol. Chem., August 17, 2001; 276(34): 31839 - 31844. [Abstract] [Full Text] [PDF]